Aligos Therapeutics—(private)—enters the HBV arena with license from Emory: https://www.globenewswire.com/news-release/2020/06/23/2052142/0/en/Aligos-Therapeutics-and-Emory-University-Announce-Expanded-License-Agreement-and-Ink-Agreement-for-Chronic-Hepatitis-B-Collaboration.html